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Background: The control of antibiotic production in Streptomyces coelicolor A3(2) involves complicated regulatory
networks with multiple regulators controlling the expression of antibiotic biosynthetic pathways. One such
regulatory network is that of the γ-butyrolactones, the so-called S. coelicolor butanolide (SCB) system. The
γ-butyrolactones in this system serve as signalling molecules and bind to the receptor protein ScbR, releasing the
repression of its target genes. The resulting expression changes affect the production of the two pigmented
antibiotics Act and Red, as well as the transcription of the cpk antibiotic biosynthesis gene cluster and the synthesis
of the γ-butyrolactones themselves.
Results: We identified a natural variant of ScbR in S. coelicolor (ScbRM600) that differs from ScbR in the
genome-sequenced strain M145 (ScbRM145) by a single amino acid change, R120S. ScbRM600 is impaired in its DNA
binding ability and alters the expression of the pathway-specific regulatory genes of the red and cpk antibiotic
biosynthesis gene clusters. Also, expression of the γ-butyrolactone biosynthesis gene scbA and production of the
signalling molecules is slightly reduced.
Conclusions: The γ-butyrolactone receptor, ScbR, plays a key role in the SCB regulatory cascade and in determining
the onset of the expression of the antibiotic regulatory genes.
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Streptomycetes show a complex morphological differen-
tiation and produce a vast variety of secondary metabo-
lites with great value in the pharmaceutical, chemical
and agricultural industries [1,2]. The genome sequence
of the model streptomycete Streptomyces coelicolor
A3(2) strain M145, has been determined and is publicly
available [3]. S. coelicolor A3(2) strains M145 and M600
are two of many strains independently derived from S.
coelicolor A3(2). Both are prototrophic plasmid-free
derivatives, but M145 was derived using both mutagen-
esis and recombination while creation of M600 did not
involve any mutagenesis [4]. Genetically, M600 differs
from M145 in that it possesses long terminal inverted
repeats (TIRs) at both ends of the chromosome, result-
ing in the duplication of 1005 genes compared to M145.* Correspondence: e.takano@rug.nl
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reproduction in any medium, provided the orThis does not, however, appear to significantly affect
total expression of the duplicated genes, since highly
similar transcript levels could be observed when com-
paring the two strains [4].
In several Streptomyces species, small autoregulatory
molecules called γ-butyrolactones are involved in con-
trolling the onset of secondary metabolite production
and morphological differentiation (reviewed in [5]).
There are numerous diverse and complex regulatory sys-
tems involving γ-butyrolactones with the signalling cas-
cade for A-factor in S. griseus being the best studied
[6,7]. In S. coelicolor, γ-butyrolactones stimulating the
production of Act and Red have been identified [8], to-
gether with the genes involved in γ-butyrolactone syn-
thesis (scbA) and γ-butyrolactone binding (scbR). ScbR
regulates transcription of both scbA and itself by binding
to the divergent promoter region controlling both genes,
and the γ-butyrolactone SCB1 inhibits this binding [9].
The regulatory influence of ScbR has been characterised
by DNA microarray analysis, and a role in directly regu-
lating a cryptic Type I polyketide biosynthetic geneLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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pathway-specific regulator cpkO was identified [10,11].
We recently reported two metabolites derived from the
hitherto orphan cpk biosynthetic pathway, the yellow
pigment yCPK and an antibiotic compound, abCPK [12].
ScbR does not, however, bind to the promoter regions of
the pathway-specific regulatory genes for Act and Red
synthesis [9], and it appears that SCB1 and scbAR do not
regulate the production of these antibiotics directly.
Nevertheless, an M145ΔscbR mutant (M752) is delayed
in the production of Act and Red [9].
ScbR is a member of the TetR protein family [13], in
which the Streptomyces γ-butyrolactone receptors show
significant similarity to each other (30–40 % amino acid
sequence identity). The crystal structure of a ScbR para-
logue in S. coelicolor, CprB, has been determined and is
assumed to generally represent the structure of γ-
butyrolactone receptors [14]. Active as homodimers,
members of the TetR family bind to highly specific DNA
binding sites in the promoter region of their target genes
and typically repress their transcription. The regulatory
region of the dimeric regulator contains one independ-
ent ligand binding pocket in each subunit. One γ-
butyrolactone receptor thus binds two ligand molecules.
Binding of γ-butyrolactones causes conformational
changes and DNA binding is relieved [14].
In this study, the S. coelicolor γ-butyrolactone recep-
tor ScbR in strain M600 (ScbRM600) was found to differ
from that in the sequenced strain M145 (ScbRM145) by
a single amino acid change. The effect of the M600-
type protein on the production of pigmented antibiotics
Act Red, and the yellow compound, yCPK, as well as
the γ-butyrolactones was assessed in vivo. In addition,
the influence of SCBR M600 on the expression of genes
involved in the butanolide system and secondary me-
tabolism was evaluated by quantitative real time PCR.Figure 1 2D gel analysis of S. coelicolor protein extracts showing the
M600. A.B. C. A part of the gels is shown with separation horizontally by is
arrows indicate ScbR from M145 (1) and M600 (2), while black arrows high
the other gels.The gels shown in A and B are representative of the results f
experiments. Panel C is a representative image chosen from two technicalThe effect onDNA and/or γ-butyrolactone binding abil-
ity of ScbR due to the amino acid substitution was also
investigated in vivo and in vitro. Sequence analysis was
used to determine the prevalence of the two forms of
ScbR among strains of S. coelicolor and S. lividans. The
ScbRM600 variant is present in only two, independent
strains of S. coelicolor and its decreased DNA binding
activity results in a delay in the transcription of the
antibiotic regulatory genes.
Results
Two forms of the γ-butyrolactone receptor ScbR in strains
of S. coelicolor
2D gel-based proteomic analysis of transition phase li-
quid cultures from S. coelicolor strain M145 identified
ScbR at a position consistent with its theoretical molecu-
lar weight and isoelectric point (spot 1 in Figure 1A).
However, in an extensive analysis of strain M600 grown
under the same conditions ScbR was never detected
(data not shown). In an analysis of protein extracts pre-
pared from spores of M600, ScbR was detected (spot 2 in
Figure 1B) but at coordinates corresponding to a signifi-
cantly more acidic isoelectric point compared to that
observed in M145. This difference was confirmed by per-
forming a separation of an equal mixture of the M600
spore extract and the M145 transition phase mycelial ex-
tract (Figure 1C), and indicates the occurrence of a modi-
fied form of ScbR in S. coelicolor strain M600.
ScbRM600 from S. coelicolor M600 carries a single amino
acid change, R120S, compared to ScbRM145 from strain
M145
To identify the M600 ScbR modification, the chymotryp-
tic peptides detected for the ScbR proteins in M145 spot
1 and M600 spot 2 in Figure 1 were compared
(Figure 2A,B,C, Additional file 1). Peptides correspondingpresence of two distinct forms of ScbR in strains M145 and
oelectric point and vertically by molecular weight. Numbered white
light landmark spots (a, b, c) known to be the same in at least one of
rom the analysis of at least two biological and three technical replicate
replicates.








52 % (87 %)







(spot 1 in Fig.1A)
ScbR M600
(spot 2 in Fig. 1B)
C
Figure 2 MALDI-TOF peptide mass fingerprint analysis of S. coelicolor strains M145 and M600 protein extracts. A. Identification of ScbR
spots 1 and 2 by mass spectrometry after tryptic and chymotryptic digest. Data from the chymotryptic digests are given in brackets. B. C. Detail
of the 1020 Da to 1090 Da mass range showing three extra peptides in ScbRM600 (spot 2 in A) (at 1041.486, 1045.492 and 1073.480 Da, marked
with circles). The extra peak at 1041.486 Da was identified as RSWHETLL by Q-TOF mass spectrometry, and the other peaks are believed to
correspond to the same peptide but with the tryptophan modified to kyneurenine (1045.492 Da) and formylkyneurenine (1073.480 Da).
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and FHFQSKEELAL (indicated by black bars in Figure 3),
were detected in the ScbR spot from M600 (Additional
file 1). Peptides containing tryptophan can produce up to
four peptide peaks in MALDI-TOF analysis due to two
successive oxidations of the tryptophan residue (i.e. par-
ent mass +16.0 Da and +32.0 Da), followed by spontan-
eous deformylation to kyneurenine (parent mass +4.0 Da)
[15], and peaks at 1126.62 Da and 1142.62 Da in the data
for the M145 spot correspond to the oxidised forms of
the parent ion detected at 1110.62 Da. Interestingly, these
three peptides are absent in the peptide mass fingerprint
for the M600 ScbR spot, but three new peptide peaks ap-
parently corresponding to a tryptophan-containing pep-
tide can be detected at 1041.48 Da, 1045.49 Da (parent
+4.0 Da), and 1073.48 Da (parent +32.0 Da; Figure 2B,C).
ScbR contains only one tryptophan residue, and the data
therefore indicate that in M600 spot 2 ScbR has been
modified on the RRWHETLL peptide resulting in a sur-
prising mass loss of 69.09 Da (and an acidic shift in the
isoelectric point value of the protein). This data corres-
pond to the replacement of an arginine residue with a
serine (69.069 Da). Analysis of the parent peptide ion at
1041.48 Da using Q-TOF mass spectrometry confirmed
the sequence of this peptide as RSWHETLL (data not
shown). This has also subsequently been verified viasequencing of the scbR gene in strain M600 (see below).
The M600-type protein (ScbRM600) therefore contains a
single amino acid change (R120S) compared to the
M145-type protein (ScbRM145) (Figure 3).
ScbRM145 is the predominant form in S. coelicolor
To survey the distribution of the dimorphism identified
in ScbR, part of the scbR coding region of 16 S. coelico-
lor strains was amplified by PCR using primers ScbRrt1
and ScbRrt2 and the sequence was determined. In
addition, to confirm the scbR sequence in S. coelicolor
M600 and S. lividans 1326, the entire scbR coding se-
quence and promoter region was amplified using pri-
mers ScbR2 and ETS10 (all primers used are listed in
Additional file 2).ThescbR in M600, a single base pair
change, c358a, was identified, confirming the amino acid
mutation R120S observed in the proteomics analysis.
The same mutation was also found in S. coelicolor strain
A(3)2 N2, but was absent in the other 14 S. coelicolor
strains tested, which all possessed the M145 genotype
(Table 1). No other variants of scbR were observed in
the strains tested. The scbR homologue in S. lividans dif-
fers from scbRM145 only by two silent point mutations,
g402a and g582t. Thus, the S. lividans ScbR amino acid
sequence is identical to that of ScbRM145. A multi-
sequence alignment of the ScbR homologues are shown
1 2 3 4

















Figure 3 Amino acid sequence alignment and deduction of functional domains for residues of CprB, ScbRM145 and ScbRM600. The
deduction of functional domains and residues is based on CprB data from [14]. The amino acid sequences represent monomers of each protein.
Peptides readily detected by MALDI-TOF analysis in ScbRM145 (spot 1 in Figure 1A) but not in ScbRM600 (spot 2 in Figure 1B) are indicated by
black bars (ScbR amino acids 48–58 and 119–126). Residues forming α-helices are boxed and labelled. Boxes are shaded for α-helices 4–8
involved in the formation of the γ-butyrolactone binding pocket. Bold boxes for α-helices 8 and 9 indicate their role in dimerization. Dashed
boxes mark the DNA binding domain (α1-3) with α2 and α3 forming a helix-turn-helix motif, and the regulatory domain (α5-10). A highly
conserved tryptophan residue directly involved in ligand binding (W127 in CprB; W121 in ScbR) is underlined. The mutated amino acid residue
120 is indicated in bold for ScbRM145 (R120) and for ScbRM600 (S120).
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251 bp upstream of scbR, covering the ScbR binding
sites of the intergenic region between divergently tran-
scribed scbA and scbR, are identical in S. coelicolor
strains M145, M600 and also in the scbR homologue of
S. lividans 1326 (data not shown). Our sequencing data
were confirmed by the publicly available genome se-
quence of S. lividans (www.broadinstitute.org/annota-
tion/genome/streptomyces_group/Regions.html).
In vivo analysis of the scbRM600 point mutation in a M145
background
Production of pigmented antibiotics in strains M145 and
M600 differ, with M600 being notably delayed in the
onset of Act and Red biosynthesis, and this is comparable
to the phenotypic change observed in strain M145 fol-
lowing deletion of scbR [9]. To determine whether the
M600 phenotype may be attributed to the point mutation
observed in scbRM600, a M145 ScbR deletion mutant was
genetically complemented with constructs expressing
either scbRM145 or scbRM600 under the native scbR
promoter.
Plasmids pTE212 and pTE214 carrying scbRM600 and
scbRM145, respectively, were used to replace the mutated
scbRM145 locus in the M145ΔscbRM145 in-frame deletion
mutant strain M752 [9] to give strains LW33 and LW34.
LW33 therefore encodes ScbRM600 in the M145 genetic
background, and LW34 is the congenic control strain
expressing ScbRM145. Correct construction of the strainswas verified using PCR and Southern analysis (Figure 4A,
B). Sequence analysis revealed a silent point mutation,
c636t (leading to an “act” triplet instead of “acc”, both
resulting in Thr), in scbRM145 of strain LW34 (pTE214).
Besides this mutation, strains LW33 and LW34 only dif-
fer by c358a in scbR.
Strains LW33 and LW34 were grown in liquid SMM.
Samples for RNA and protein isolation, as well as for γ-
butyrolactone and antibiotic analysis, were collected at
different phases of growth (Table 2).
Antibiotic production in S. coelicolor LW34 and LW33 is
comparable
No difference could be determined for Act production.
This was consistent between two independent growth
experiments (Table 2). For Red, production increased 2-
fold in LW33 for GC 2 but the increase was not seen in
GC 1 (Table 2).
We recently identified a yellow pigment (yCPK) and
an antibiotic compound (abCPK) as metabolites of the
hitherto orphan cpk gene cluster [12] that may be the
primary target of the S. coelicolor butanolide system.
Therefore, in addition to Act and Red, we compared the
production of the yellow compound in LW33 and LW34
grown on solid Difco Nutrient agar supplemented with
glutamate where yCPK was found to be produced in
high yields by the parental strain M145 [12]. The two
tested strains showed no obvious difference in the pro-
duction of all three pigmented secondary metabolites
Table 1 Bacterial strains used in this study












11 pheA1 scbRM145 [4]
13 uraA1 scbRM145 [4]
210 ura-3 scbRM145 [4]
290 cys-4 scbRM145 [4]
380 glu-3 scbRM145 [4]
505 cysC3 scbRM145 [4]
A3(2) N1 A3(2) isolate scbRM145 [4]
A3(2) N2 A3(2) isolate scbRM600 [4]
A3(2) N3 A3(2) isolate scbRM145 [4]
A3(2)-Stanford A3(2) isolate scbRM145 [4]
CH999 proA1 argA1 redD60
Δact::ermE SCP1- SCP2-
scbRM145 [4]
J1501 hisA1 uraA1 strA1
pgl-1 SCP1- SCP2-
scbRM145 [18]
LW33 M752+ scbRM600 scbRM600 This study
LW34 M752+ scbRM145 scbRM145 This study
M132 pheA1 SCP1- SCP2- scbRM145 [4]
M145 SCP1- SCP2- scbRM145 [19]
M600 SCP1- SCP2- scbRM600 [20]
M752 M145 ΔscbR - [9]
W3443 wild type scbRM145 [4]
Streptomyces lividans
1326 wild type scbRM145 homologue [18]
Figure 4 Verification of full-length scbRM145/M600 in S. coelicolor
strains LW34 and LW33. A. PCR was carried out using primers
ETseq3 and ETS7 to amplify a 752 bp full-length scbRM145/M600
fragment and a 317 bp fragment from the ΔscbR region. The 317 bp
PCR product was only found with the LW33/LW34 parental
M145ΔscbR mutant. A full-length scbRM145/M600fragment was
amplified from a wt control (M145) and from LW33 and LW34.
Obtained PCR products are indicated with arrows on the left; sizes
of the marker bands are given on the right. The M145-/M600-type of
the gene was confirmed by DNA sequence analysis (data not
shown). B. Southern analysis was carried out using NcoI digested
genomic DNA of the four strains. A DIG-labelled DNA probe was
used to detect the expected 3.2 kb fragment with M145ΔscbR and
2.37 kb fragments with the wt control (M145) and LW33 and LW34.
Detected DNA fragments are indicated with arrows on the left; sizes
of the marker bands are given on the right. C. PCR was carried out
using primers RCseq31 and scbR-M145_c358 (scbR-M600_c358a) to
amplify a 2.8 kb scbRM145 (scbRM600)fragment. The latter are specific
for the base change between the two scbR variants. A scbRM145
fragment was only obtained with control strain M145 and with
LW34, whereas control strain M600 and LW33 showed a scbRM600
specific PCR product. Using water as template did not give any
product. Obtained PCR products are labelled with arrows on the left;
a 2.5 kb marker band is indicated on the right.
Gottelt et al. BMC Research Notes 2012, 5:379 Page 5 of 17
http://www.biomedcentral.com/1756-0500/5/379during ten days of growth (Figure 5). From all these data
there seems to be no significant difference in antibiotic
production between LW33 and LW34 under the condi-
tions tested, demonstrating that the difference in ScbR
isoform does not explain the phenotypic difference of
M145 and M600.
γ-butyrolactone production is slightly delayed in LW33
γ-butyrolactone production of S. coelicolor strains LW34
and LW33 was determined using a kanamycin bioassay
[21] at different phases of growth (Table 2, GC 2) corre-
sponding to the sampling time points in the transcrip-
tion analysis. Kanamycin resistance of a Streptomyces
indicator strain is induced by the presence of γ-butyrolactones in extracts from the tested strains, and
the extent of growth of the indicator strain on media
containing kanamycin reflects the amount of γ-
butyrolactones produced [21]. Extracts from stationary
phase cultures of LW33 and LW34 produced similar
Table 2 Growth and antibiotic production of LW34 and LW33
Growth Curve 1 (GC 1) Growth Curve 2 (GC 2)
time point 1 2 3 4 1 2 3 4
growth phase eT mT lT S eT mT lT S
OD450 (hours) LW34 1.00 (21) 1.21 (23) 1.26 (245) 1.45 (43) 1.25 (18) 1.49 (20) 1.62 (22) 1.92 (40)
LW33 1.04 (21) 1.18 (23) 1.25 (245) 1.42 (43) 1.56 (18) 1.38 (20) 1.58 (215) 1.23 (40)
Red LW34 0.3 0.6 0.9 3.9 0.1 0.2 0.6 0.7
LW33 0.5 0.7 1.0 3.7 0.0 0.2 1.1 2.1
Act LW34 0.0 0.0 0.0 1.0 0.2 0.1 0.1 0.5
LW33 0.0 0.0 0.0 1.0 0.1 0.1 0.1 0.7
S. coelicolor LW34 and LW33 were grown in duplo in liquid SMM (growth curves (GC) 1 and 2). Samples were taken at different phases of growth (early, mid and
late transition (eT, mT, lT), and stationary (S) phase). The sampling time is given in hours of growth in brackets underneath the determined OD450. Production of
actinorhodin (Act) and (undecyl-) prodiginines (Red) is given in μg /dry cell weight mg-1.
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of γ-butyrolactones. Slightly higher levels were detected
with mid and late transition phase samples in strain
LW34 (Figure 6). This would indicate that ScbRM600 in
strain LW33 leads to a minor reduction and delay in γ-
butyrolactone production compared to LW34, and is
consistent with the delay in scbA transcription observed
in LW33 as shown below (Figure 7).Expression of scbR, scbA, redD and cpkO is altered in
strain LW33 containing the mutant ScbRM600
Quantitative real time PCR (qRT-PCR) was used to
measure the expression levels of the pathway-specific
regulators of the act (actII-ORF4), red (redD) and the
cpk (cpkO) antibiotic biosynthesis gene clusters, and of
scbA and scbR of the S. coelicolor butanolide system in
the presence of the two forms of ScbR (Figure 7).
Compared to the control strain LW34, redD expres-
sion was 2.5-fold lower at mid transition phase (mT)
in LW33 harbouring the ScbRM600. RedD expression
did not change dramatically from mid transition to late
transition phase in LW33, while in LW34, the expres-
sion dramatically decreased. This resulted in a >2-fold
higherredD expression in LW33 compared to LW34 at
late transition phase. For GC 2, The onset of actII-
ORF4 transcription was delayed in LW33 but this was
not observed in GC 1. Expression of cpkO was onlyFigure 5 Secondary metabolite production in solid culture. S. coelicolo
glutamate-supplemented Difco Nutrient agar at 30 °C. Production of pigme
48 h and 3, 6, 10 days.transcribed in late transition phase (lT), and thus later
than in LW34. Also, the onset of scbAtranscription
was delayed in LW33 and shifted from mid to late
transition. Also with scbR, maximum expression was
reached only at late transition phase in LW33 com-
pared to mid transition phase in LW34 (Figure 7 and
Additional file 4AB).ScbRM600 from Streptomyces shows reduced ability to
bind to the scbR promoter sequence
Cell-free extracts (CE) of LW34 (scbRM145) and LW33
(scbRM600) were prepared from samples taken at differ-
ent phases of growth (Table 2) corresponding to the
sampling time points in the transcription analysis. DNA
binding ability was determined in gel retardation assays
using a digoxygenin-labelled scbR promoter fragment
containing the ScbR binding site upstream of its own
promoter [9] and freshly prepared protein extracts
(Figure 8A; shown for GC 1). Equivalent amounts of
total protein used for the gel retardation analysis were
also analysed by Western hybridization using an anti-
body to ScbR to determine the relative abundance of
ScbR in the extracts (Figure 8B). Extracts from LW34
from late transition and stationary phase completely
shifted the operator DNA in the binding assay
(Figure 8A). This is consistent with the appearance of
ScbR as detected by Western blotting (Figure 8B). Inr strains LW34 (scbRM145) and LW33 (scbRM600) were incubated on
nted secondary metabolites was followed at 21, 22.5, 24, 25.5, 27.5, 43,
Figure 6 γ-Butyrolactone production in liquid S. coelicolor cultures using the kanamycin bioassay. The kanamycin bioassay [21] was used
to detect γ-butyrolactone production in S. coelicolor in liquid SMM at four time points (tp 1–4) during different phases of growth indicated with
eT, mT, lT and S (early, mid, late transition, and stationary phase; also see Table 2, GC 2). Growth of a bioassay indicator strain on kanamycin
supplemented medium is shown. Kanamycin resistance and thus growth is induced by the presence of γ-butyrolactones. Extracts from strains
LW34 and LW33, containing ScbRM145 and ScbRM600, respectively, resembled each other in the induction of growth, however, with LW34 sparse
growth seems to be induced already at time point 2 and the area of growth is increased compared to LW33 with the late transition phase
sample. Chemically synthesised S. coelicolor γ-butyrolactone (SCB1) was used as positive, the solvent methanol as negative control.
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Even in the presence of a higher amount of ScbRM600
compared to ScbRM145 (LW33 in stationary and LW34



























































tp1 tp2 tp3 tp4
eT lT
red
Figure 7 Transcriptional analysis of redD,actII-orf4,cpkO,scbAandscbA
transcription of redD, actII-orf4, cpkO, scbA and scbRM145/M600 using cDNA syn
(scbRM145) and LW33 (scbRM600). Samples were taken at four time points (tp 1
(early, mid, late transition, Sand stationary phase). Gene expression is shown
sample. Error bars indicate the standard deviation of each three technical repshift of ScbRM600 was weaker, suggesting that the DNA
binding ability of the mutant protein in LW33 is































and scbRM145/M600 using qRT-PCR. qRT-PCR analysis of the
thesized from RNA isolated from liquid SMM cultures of S. coelicolorLW34
–4) during different phases of growth indicated with eT, mT, lT and S
as fold-change relative to the LW34 time point 1 early transition phase
licates. For numerical data see Additional file 4A and 4B.
Figure 8 Gel retardation assay and Western analysis using S. coelicolor cell-free extracts. Cell-free extracts (CE) of S. coelicolor LW34
(scbRM145) and LW33 (scbRM600)obtained at four time points (tp 1–4) during different phases of growth indicated with eT, mT, lT and S (early, mid,
late transition, and stationary phase; also see Table 2, GC 1) were used to determine presence and DNA binding ability of ScbRM145/M600. CE from
E. coli JM101/pIJ6120 harbouring ScbRM145 was used as a positive control (indicated with a “+”). A. DNA binding abilities of ScbRM145 and
ScbRM600 from S. coelicolor CE were tested using a DIG-labelled scbR promoter DNA fragment by gel retardation analysis. The scbR promoter DNA
fragment and DNA/protein complexes are indicated by arrows. The DNA probe alone was used as a negative control (indicated with a “-“). B.
Western analysis of ScbR. ScbRM145 (+, LW34) and ScbRM600 (LW33) was detected in similar amounts at corresponding time points in the two S.
coelicolor strains. ScbR signals are indicated by an arrow.
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in E. coli indicates that the DNA and γ-butyrolactone
binding abilities of ScbRM145 and ScbRM600 are
comparable
In vivo analysis in this study indicated that expression of
mutant ScbRM600 in S. coelicolor leads to altered patterns
of expression of the pathway-specific regulatory genes
for Red (redD) and CPK (cpkO), the scbA and scbR genes
known to be controlled by ScbR in response to altered
butyrolactone concentrations, and to a decreased
ScbRM600 DNA binding affinity. To investigate in more
detail the effect that the point mutation may have on the
ability to bind both butyrolactones and its cognate DNA
operator sequence, ScbRM145 and ScbRM600 were overex-
pressed in E. coli. Freshly prepared E. coli CE containing
equal amounts (Methods; Figure 9B) of the two forms of
ScbR showed comparable DNA binding abilities in gel
retardation analysis (Figure 10, lanes 3 and 7, and
Figure 11A, lanes 2 and 6, respectively).
Addition of low (8 ng; Figure 10, lanes 5 and 9) and
high (63 ng; Figure 10, lanes 4 and 8) amounts of the
cognate γ-butyrolactone ligand SCB1 led to a partial and
a complete loss of DNA binding, respectively, with both
ScbRM145 and ScbRM600. Therefore, under the conditions
tested, the γ-butyrolactone binding affinity of the two
forms of ScbR expressed in E. coli were comparable.
DNA binding ability of ScbRM600 expressed in E. coli is
unstable
In gel retardation analysis using E. coli CE supplemented
with 4 % (v/v) glycerol, DNA binding of the mutated
ScbRM600 was reduced when stored at −20 °C for severaldays or weeks (data not shown). To further analyse this
difference, fresh CE without glycerol was frozen and
thawed up to three times at −20 °C and 37 °C, respect-
ively, and the DNA binding affinity was tested by gel re-
tardation analysis. To ensure equal amounts of protein
for both ScbRM145 and ScbRM600, total protein concen-
trations of the CE were measured, and the abundance of
ScbR present was confirmed by Western analysis
(Figure 11B). Both proteins were active in freshly pre-
pared and analysed CE (Figure 11A, lanes 2 and 6), but
freezing and thawing of the proteins lead to a decrease
(lane 7 and 8) and eventually to the loss (lane 9) of DNA
binding with the mutant ScbRM600. Native ScbRM145 was
not affected by the treatment (lanes 3 to 5). Western ana-
lysis indicated that freezing and thawing had no effect on
the amount of protein detected (Figure 11B) indicating
that the loss of DNA binding ability was not due to pro-
tein degradation. This suggests that compared to
ScbRM145, the DNA binding ability of ScbRM600 is signifi-
cantly less stable. This is also supported by the decrease
in DNA binding affinity observed with the mutant pro-
tein, but not with ScbRM145, in the presence of methanol
(Figure 10, lanes 6 and 10). This instability of ScbRM600
DNA binding activity was also seen from crude extracts
obtained from Streptomyces (data not shown).
Discussion
A variant form of the γ-butyrolactone receptor ScbR in
S. coelicolor
In addition to ScbR from the sequenced strain M145
(ScbRM145), a natural variant of the protein, ScbR/R120S
(ScbRM600), was found in strain M600 (this study). The
Figure 9 Heterologous expression and Western analysis of ScbR. A. Heterologous expression and purification of ScbRM145 for the creation of
ScbR antibodies. Crude cell extracts from E. coli JM101 harbouring pTE88 before (lane 1) and after (lane 2) induction with 0.2 % (w/v) of L-
rhamnose. The MalE-ScbRM145 fusion protein present in the induced fraction was then purified with an amylose resin (lane 3). MalE-ScbRM145 was
cleaved with Factor Xa to separate MalE from ScbRM145 (lane 4). ScbRM145 was further purified with a heparin column (lane 5). Arrows show the
protein bands representing each protein. Theoretical molecular weight of MalE-ScbRM145, MalE and ScbRM145 are noted in brackets. All protein
fractions were analysed on 12 % (w/v) SDS-PAGE followed by staining with Coomassie blue. M denotes for prestained protein molecular weight
ladders (SM0431 (old version) (Fermentas).and Precision Plus Protein “All Blue” Standard (BioRad)). B. Heterologous expression of ScbRM145 and
ScbRM600 for gel retardation assays and Western analysis of both forms of ScbR. ScbR-antibodies were generated using recombinant ScbRM145
shown in (a). ScbRM145 and ScbRM600 were expressed in E. coli JM101/pIJ6120 and pTE58 harbouring scbRM145 and scbRM600, respectively. In
Western analysis, ScbR was detected with a sample of the recombinant ScbRM145 (“rScbRM145”) and in cell-free extracts (CE) of E. coli JM101/
pIJ6120 and pTE58 (“ScbRM145” and “ScbRM600”). In CE of E. coli JM101 harbouring the empty expression vector pIJ2925 (“E. coli CE”) no ScbR was
found. Comparable amounts of ScbR were detected with same amounts of total CE proteins.
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also found in strain A3(2) N2, another S. coelicolor A3
(2) derivative independent from both M145 and M600
[4]. All 14 further strains tested showed the M145 geno-
type, including S. coelicolor W3443, the proposed pro-
genitor of all strains described [4], and scbRM600 is thus
regarded as a mutant variant. When mapping the known
instances of this variant onto the lineage of S. coelicolor
described by Kao and co-workers [4], our results indi-
cate that the point mutation c358a occurred on two in-
dependent occasions, in strains M600 and A3(2) N2,
perhaps indicating a selective pressure or an evolution-
ary relevance for this change under certain conditions.
The amino acid change in ScbRM600 impairs DNA binding
in S. coelicolor
Compared to ScbRM145, DNA binding was reduced with
ScbRM600 (from S. coelicolor LW34 and LW33, respect-
ively; Figure 8). This difference is surprising since the
functional localization of the altered amino acid 120 does
not suggest an effect of the mutation in scbRM600 on the
DNA binding domain of the protein. Furthermore,Horinouchi and co-workers described the helix-turn-
helix motifs of mutant ArpA/W119A as still able to bind
DNA [22]. However, in the ArpA study the intensity of
the shifted band observed in the absence of A-factor was
noticeably weaker for the mutated ArpA/W119A than
for the wild type ArpA [22]. This also implies a reduced
DNA binding affinity of ArpA/W119A, and thus suggests
an effect of the amino acid change W119A in ArpA simi-
lar to that observed with ScbRM600 in this study. It is
interesting to note that both variants of ScbR expressed
in E.coli did not have any difference in DNA binding ac-
tivity. This may suggest another component in S. coelico-
lor is responsible for the loss of the DNA binding activity
of ScbR.
The mutation in ScbRM600 has no detectable effect on γ-
butyrolactone binding
The crystal structure of a ScbR paralogue in S. coelicolor,
CprB, is regarded as representative for γ-butyrolactone
receptors in streptomycetes. Functional domains for
dimerization, DNA binding by helix-turn-helix motifs,
and γ-butyrolactone binding have been proposed. DNA
Figure 10 Gel retardation assay using ScbRM145 and ScbRM600from E. coli supplemented with SCB1. DNA and γ-butyrolactone binding
abilities of ScbRM145 and ScbRM600 from E. coli cell-free extracts (CE) were tested using a DIG-labelled scbR promoter DNA fragment and the S.
coelicolor γ-butyrolactone SCB1 in a gel retardation assay. All samples contained the labelled DNA probe. Sample two contained CE of E. coli/
pIJ2925 (“E. coli CE”), samples 3–6 and 7–10 of E. coli JM101/pIJ6120 and pTE58 (“ScbRM145” and “ScbRM600”). To samples 4, 5, 8 and 9 SCB1
dissolved in methanol was added in high (63 ng) and low (8 ng) amounts. Samples 6 and 10 were supplemented with same volumes of pure
methanol. The scbR promoter DNA fragment and DNA/protein complexes formed with ScbRM145/M600 are indicated by arrows. DNA binding
abilities of the two variants of ScbR were shown to be the same in the absence and the presence of the γ-butyrolactone.
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putative cognate γ-butyrolactone ligand has yet to be
identified [14]. From the CprB amino acid sequence,
amino acid 120 in ScbR is proposed to form part of a
central α-helix (α7) in the regulatory region (Figure 3).
The adjacent tryptophan residue W121 is predicted to
be directly involved in forming the γ-butyrolactoneFigure 11 Gel retardation assay and Western analysis using ScbRM145
binding abilities of ScbRM145 and ScbRM600 from E. coli cell-free extracts (CE
gel retardation assay. All samples contained the labelled DNA probe. Samp
(“ScbRM145” and “ScbRM600”), respectively, frozen and thawed up to three tim
fragment and DNA/protein complexes formed with ScbRM145/M600 are indic
shown to be unstable under the conditions tested. B. Western analysis of S
recombinant ScbRM145 (“rScbRM145”, lane 1) and in comparable amounts in
described in A (lanes 2–9). ScbR bands are indicated by an arrow.binding pocket and is highly conserved among Strepto-
myces γ-butyrolactone receptors [14]. Mutation of the
corresponding W119 in the A-factor receptor protein
ArpA, a ScbR homologue in S. griseus, abolished γ-
butyrolactone binding [22]. It therefore seems reason-
able to suggest that a change in the amino acid residue
120 adjacent to the crucial W121 in ScbR, from a largeand ScbRM600 from E. coli after freezing and thawing. A. DNA
) were tested using a DIG-labelled scbR promoter DNA fragment in a
les 2–5 and 6–9 contained CE of E. coli JM101/pIJ6120 and pTE58
es before added to the DNA probe. The scbR promoter DNA
ated by arrows. In contrast to ScbRM145, DNA binding of ScbRM600 was
cbR. ScbRM145 was detected with a positive control sample of
all gel retardation assay samples harbouring ScbRM145 or ScbRM600 as
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serine, could affect ligand binding affinity.
However, no difference in ligand binding was observed
between ScbRM145 and ScbRM600 (Figure 10), and it is
interesting to note that ScbR amino acid 120 is not con-
served among γ-butyrolactone receptor proteins. The
corresponding residues in other ScbR homologues con-
sist of members of all classes of amino acids and of
hugely differing sizes (e.g., aspartate (acidic, 133 Da) in
ArpA (S. griseus); arginine (basic, 174 Da) in ScbRM145;
asparagine (hydrophilic, 132 Da) in FarA (S. lavendulae);
alanine (hydrophobic, 89 Da) in SpbR (S. pristinaespira-
lis)), all adjacent to the conserved tryptophan residue
[14]. The high level of variability at this position suggests
residue 120 does not in fact play a significant role in γ-
butyrolactone binding.
ScbRM600 leads to altered gene expression and has some
effects on γ-butyrolactone production
Expression of scbA is delayed in LW33 (Figure 7). This
could be a direct effect of the impaired DNA binding
ability of ScbRM600 since ScbR was previously shown to
be necessary for scbA expression [9]. Consistently, late
expression of the γ-butyrolactone synthase gene coin-
cides with a slight delay in the production of the small
signalling molecules in LW33 (Figure 6).
Also scbR expression is somewhat delayed at similar
transcription levels in the presence of the M600-type
protein, but not as clearly as with scbA (Figure 7). This
is at first glance surprising, since a reduction in DNA
binding of the auto-repressor might be expected to re-
sult in a higher or early expression of scbRM600. How-
ever, also in Western analysis no increase in the amount
of ScbRM600 in LW33 was observed (Figure 8B). γ-
butyrolactones abolish the DNA binding of ScbR and
are active in nM concentrations (Figure 10) [9]. The
small reduction in γ-butyrolactone production observed
in LW33 (Figure 6) may promote binding of ScbRM600
to its target sites in vivo, counteracting the impaired
binding ability of the mutant protein.
In LW33, expression of the pathway-specific regulator
genes for the red and the cpk antibiotic biosynthesis
gene clusters was delayed compared to that in LW34
(Figure 7 and Additional file 4AB). However expression
of scbR, scbA, redD, cpkO and actII-orf4 has been shown
to be highly similar in M145 and M600 in an extensive
genome-wide study by Weaver and co-workers [4]. Des-
pite these differences, antibiotic production was similar
in the LW33 and LW34. Regulation of production of
these antibiotics is complex and known to be affected by
many additional factors [23].The cpk gene cluster, for ex-
ample, was shown to be also regulated by the RapA1/A2
two-component system [24] and the global regulator
DasR [25]. It appears that the changes in expression ofthe regulatory genes observed here are over-ridden by
other control mechanisms and so do not result in any
observable change in the antibiotic phenotype. Further-
more, production of other, known and unknown, sec-
ondary metabolites in S. coelicolor might impair the
synthesis of Act, Red and yCPK, e.g. by competition for
common precursors from primary metabolism. Further
experiments will be needed to reveal the detailed effects
of the mutation in ScbRM600 on the delicately balanced
butanolide system in S. coelicolor.
Despite the somewhat impaired DNA binding ability
of the mutant ScbRM600, our result show that strain
LW33 clearly differs from a M145ΔscbR in-frame dele-
tion mutant (M752). In comparison to M145, the latter
strain is delayed in Red production, transcribes scbR
early, and expresses cpkO early and constitutively [9,10].
Evidently, the single R120S amino acid change has a dif-
ferent impact on the S. coelicolor butanolide system and
related secondary metabolites when compared to a
complete deletion. The antibiotic production in M600
also resembles that of the M145ΔscbR in-frame deletion
mutant (M752) where all antibiotics are produced later
than M145. We have shown that the cause of this anti-
biotic production phenotype is not due to the point mu-
tation in ScbR alone.
Structural effect of amino acid change R120S on the DNA
binding domain of ScbRM600
DNA binding of ScbRM600 was impaired in both the nat-
ural producer S. coelicolor and, after harsh low-
temperature treatment, in E. coli CE. The decreased
binding ability is therefore most probably not related to
specific properties of the S. coelicolor cellular back-
ground, e.g. a hypothetical “deactivation” mechanism of
the transcriptional regulator ScbR, and it is more likely
that the amino acid change is causing a structural change
affecting the DNA binding domain. This is also sup-
ported by the fact that a loss of ScbRM600 DNA binding
could be induced by freezing and thawing of the protein
(Figure 11A), and the observation that this loss was pre-
vented by the addition of 43 % (v/v) of glycerol (data not
shown). However, modelling of both ScbR variants based
on the crystal structure of the ScbR paralogue CprB [14]
does not reveal an obvious destabilizing effect of the mu-
tation R120S in ScbRM600 (data not shown; Dirk Linke,
personal communication). Also, protein aggregation, spe-
cifically of the mutated ScbRM600, could cause these
effects, whereas Western analysis data shown in
Figure 8B and Figure 11B clearly exclude degradation of
the protein as an explanation for our observations. Pre-
diction of enzymatic cleavage using the ExPASy Peptide
Cutter (Swiss Institute of Bioinformatics (SIB)) (http://
expasy.org/tools/peptidecutter/) only revealed an add-
itional cleavage site for pepsin at pH1.3 (and not pH> 2)
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proteinase, clostripain and trypsin (data not shown).The mutation in ScbRM600 is not responsible for the
absence of the protein in vegetative mycelium of strain
M600
To our surprise and in contrast to M145, ScbRM600 was
absent during vegetative growth in M600 as shown by
2D gel (Figure 1) and Western analysis (data not shown).
However, ScbRM600 was present in vegetative mycelium
of S. coelicolor LW33 harbouring scbRM600 in an M145
genetic background. The amounts were comparable to
ScbRM145 in the control strain LW34 (Figure 8B) and in
M145 (data not shown). This suggests that it is the
M600 genetic background, and not the amino acid
change in ScbRM600, that is the reason for the absence of
ScbR during vegetative growth of M600. Whether the
altered properties of ScbRM600 are an adaptation to its
synthesis in the spores of S. coelicolor M600 and/or to a
putative modified function of the regulator which again
might indicate evolutionary relevance remains to be
determined. Detailed knowledge of the butanolide regu-
latory system in S. coelicolor might allow rational con-
struction of strains with improved timing and levels of
antibiotic production.Conclusions
Among at least five paralogues in S. coelicolor (CprA,
CprB, SCO6323, ScbR and ScbR2), ScbR is the only γ-
butyrolactone receptor experimentally shown to bind a
cognate signalling molecule. Recently, SCO0608 (SlbR)
was shown to also bind to butyrolactones with less
specificity compared to ScbR, in vitro and shares simi-
lar recognition sites as ScbR. However the effect on
antibiotic production is much less dramatic than that
of ScbR [19,21]. Therefore ScbR still plays a key role
in the S. coelicolor butanolide system involved in the
regulation of the antibiotics Act and Red, and of the
cpk secondary metabolite gene cluster (reviewed in
[5]). We identified a variant ScbR with only one amino
acid exchange in S. coelicolor M600 that is impaired in
its DNA binding ability and alters the expression of
the pathway-specific regulators of two antibiotic bio-
synthetic gene clusters. This demonstrates that the γ-
butyrolactone receptor, ScbR, plays a key role in the
SCB regulatory cascade and in determining the onset
of the expression of the antibiotic regulatory genes.
This variant was only found in two Streptomyces coeli-
color strains which most likely arose in laboratory con-
ditions. To understand how this variant was selected
twice may shed light on the evolutionary diversity of
signalling receptor molecules.Availability of supporting data
The data sets supporting the results of this article are
included within the article and its additional files.
Methods
Bacterial strains, plasmids and cosmids
Strains and vectors used in this study are listed in Table 1
and Additional file 5. Streptomyces was manipulated as
described previously [18]. Escherichia coli was grown
and transformed according to [16].
Culture conditions
For culturing E. coli, liquid LB [16] or LB agar supple-
mented with appropriate antibiotics was used. For gen-
omic DNA isolation Streptomyces was grown in liquid
YEME/TSB (1:1) medium as described [18]. MS medium
[18] was used to harvest spores according to [18]. To de-
termine the viable spore concentration, dilution series of
spore suspensions were plated on MS or DNA medium
(DNagar) [18] and the number of colony forming units
was determined. DNAgar supplemented with 325 mM
(final conc.) L-Glutamic acid monosodium salt (Glu-
DNAgar) [12] was used for determination of secondary
metabolite production. For liquid Streptomyces cultures,
strains were cultivated using SMM as previously
described [9,19]. Interspecific conjugation was done as
described previously [9].
PCR and DNA sequencing
Amplification of DNA by PCR [26] was done with Taq
polymerase (Fermentas), ProofStart polymerase (Qiagen)
or the Expand High Fidelity DNA System (Roche). DNA
sequence analysis was carried out by Sequence Labora-
tories, Göttingen, Germany.
DNA manipulation, plasmid transformation and
intergeneric transfer
Plasmid DNA isolation, restrictions and cloning experi-
ments were carried out as described in [16]. Strepto-
myces was manipulated as described in [2], genomic
DNA was isolated according to [27].
2D gel electrophoresis and MALDI-TOF mass
spectrometry
Protein extracts were prepared from typically 25 ml
culture samples according to [28] and mycelial pellets
were stored at -80 °C until use. To prepare total pro-
tein extracts from spores, spores harvested from cul-
tures grown on MS plates [18] and stored frozen in
glycerol at −80 °C were thawed on ice, washed once
with ice cold wash buffer [28], then transferred to a
mortar submerged in liquid nitrogen together with an
equal volume of washed glass beads (Sigma G-8893,
106 microns). The spores were then ground thoroughly
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consistency (about 5 min), and the resulting frozen
powder stored at −80 °C until use. Frozen aliquots
were suspended in spore protein buffer (50 mM DTT,
4 mM Pefabloc SC protease inhibitor, 40 mM Tris pH
9.0, 1 mM EDTA, 1 mM EGTA and 2 % (w/v) SDS),
sonicated briefly (Sanyo Soniprep 150; 2 x 5 second
bursts at amplitude 7.5 microns), and then boiled for
10 min. After cooling, cell debris and glass beads were
removed, the protein extract was cleaned up, and pro-
tein pellets were finally dissolved and stored frozen in
aliquots at −80 °C until use as described in [28]. Pro-
tein extracts from mycelia and spores were subjected
to 2D gel electrophoresis as detailed in [28]. The strip
used for the separation was an 18 cm pH 5.5-6.7 IPG
strip (Amersham Biosciences). Gels were stained with
Sypro Ruby (Bio Rad) according to the manufacturer’s
instructions, and scanned using the Perkin-Elmer
ProXPRESS proteomic imaging system using excitation
and emission wavelengths of 480 nm and 630 nm,
respectively.
Protein spots of interest were excised from stained gels
using the Investigator ProPic robot from Genomic Solu-
tions, and identified by tryptic or chymotryptic digestion
and MALDI-TOF mass spectrometry using a Micromass
Q-TOF 2 mass spectrometer as previously described
[28]. Identification of proteins from peptide mass finger-
print data was performed according to [28].
Overexpression and purification of ScbRM145 for the
generation of ScbR antibodies
The scbRM145 coding sequence was amplified by PCR
from the cosmid SCAH10 [29] using primers MalE-
ScbR1 and MalE-ScbR2 (Additional file 2). The PCR
product was gel-purified and ligated to pDRIVE
(Qiagen), yielding pDRIVE-ScbR. This plasmid was
digested with BamHI and HindIII and the fragment cor-
responding to scbRM145 was ligated to the digested
BamHI/HindIII vector pTST101 [30] to allow the trans-
lational fusion of scbRM145 with malE, leading to pTE88.
The sequence of scbRM145 and the translational fusion
were confirmed by DNA sequencing.
E. coli JM101 was transformed with pTE88. LB with 50
μg ampicillin ml-1 was inoculated to 1/100 volume with
the overnight pre-culture and cells were grown at 37 °C
until OD600 reached 0.5. L-rhamnose (0.2 % (w/v) final
concentration) was added for induction. After a further 2
h of incubation the induced cells were harvested and
washed twice with chilled Column Buffer (CB) (20
mMTris-HCl, 200 mM NaCl, 1 mM EDTA), resuspended
in chilled CB and disrupted using a French-Press. The
soluble fraction containing MalE-ScbRM145 was aliquoted
and frozen at -70 °C until use. The MalE-ScbRM145 was
further purified by affinity chromatography with amyloseresin (New England Biolabs) using a Bio-Logic FPLC sys-
tem (Bio-Rad). After elution with CB supplemented with
10 mM maltose, positive fractions (0.5-5 mg ml-1)
detected by UV absorbance at 280 nm and shown to con-
tain MalE-ScbRM145 (66.4 kDa) by SDS-PAGE were
pooled. ScbRM145 was cleaved from MalE by the specific
protease Factor Xa (10 μg ml-1 final concentration, New
England Biolabs). Complete cleavage was determined by
SDS-PAGE and cleavage was stopped by adding 2x
Protease Inhibitor Cocktail (Roche). ScbRM145 (23.8
kDa) was further purified to homogeneity by affinity
chromatography using a heparin column (Amersham
Biosciences) coupled to the Bio-Logic FPLC system
(Bio-Rad). ScbRM145 was eluted using a continuous salt gra-
dient (0.2-2 M NaCl in CB). Positive fractions were checked
on SDS-PAGE for presence and purity of ScbRM145
(Figure 9). The purified protein (0.8 mg) was used to
generate antibodies in rabbits (Eurogentec S.A., Belgium).SDS-PAGE and Western analysis
Cell-free extracts (CE) or purified ScbR were resolved by
SDS-PAGE (12 % (w/v) resolving SDS-polyacrylamide
gels) according to Laemmli’s procedure [31]. Following
electrophoresis, resolved bands were visualized by Coo-
massie brilliant blue staining. For Western analysis,
proteins separated on SDS-PAGE gels were transferred
to a nitrocellulose membrane by immersion or semi-
dry blotting. Immunodetection of ScbR was carried out
by using rabbit antiserum raised against ScbRM145 (this
study) and horseradish peroxidase-conjugated goat
anti-rabbit IgG (Bio-Rad) as a secondary antibody with
Roche’s CSP-Star (Figure 11B and Figure 9B) or NBT/
BCIP (Figure 7B) as a substrate. In the former case,
Super RX Medical X-ray Film (NIF100) (Fuji film) and
a Lumi-Imager F1 (Roche) (Figure 11B) or a Konica
QX-150U Medical Film Processor (Figure 9B) were
used for detection.Construction of the ScbRM600 expression plasmid and
expression of both forms of ScbR in E. coli
A scbRM600 expression vector, pTE58, was constructed
as described in detail in Additional file 6A, B. Plasmid
pTE58 and the scbRM145 expression construct pIJ6120
[9] contain the two forms of scbR with its own promoter
region cloned behind the lacZ promoter in a pIJ2925
backbone. Expression constructs pTE58 and pIJ6120
were partially sequenced and differ only by the natural
point mutation in scbRM600 (this study). E. coli JM101
was transformed with pTE58 and pIJ6120 for heterol-
ogous expression of ScbRM600 and ScbRM145 and CE was
used for Western hybridisation analysis and gel retard-
ation assays.
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For E. coli cell-free extract (CE), 10 ml LB overnight cul-
tures of E. coli JM101 harbouring pIJ2925, pIJ6120 and
pTE58 were inoculated at a 1/100 concentration in 50
ml LB without glucose. Cultures were incubated at 37 °C
for 2.5 h or until OD600 0.7-0.8 and induced with 1 mM
(final concentration) IPTG. After 3 h of further incuba-
tion cells were harvested and washed twice with ice cold
disruption buffer (50 mM TrisHCl pH 7.9, 1 mM EDTA
pH 8.0, 1 mM DTT, 1x (final conc.) complete EDTA-
free protease inhibitor (Roche)) before being resus-
pended in 400 μl disruption buffer. For the E. coli CE
used as positive control in Figure 7 the disruption buffer
contained 20% (v/v; final conc.) glycerol. Cells of 100 μl
aliquots were collected by centrifugation, the super-
natant was removed completely and the cell pellet was
frozen at −80 °C. To prepare CE, cells were resuspended
in 150 or 200 μl disruption buffer and were disrupted by
sonication. The cell lysate was clarified by centrifugation.
Total protein concentration of the supernatant was
determined using the BCA Protein Assay kit (Pierce)
(for Figure 10 and Figure 9B) or a NanoDrop spectro-
photometer (Thermo Fisher Scientific) (for Figure 7 and
Figure 11). The freshly prepared CE was used immedi-
ately (Figure 10 and Figure 9B (100 μg total CE protein
used), and Figure 7 (50 μg)). For Figure 11, the CE (130
μg total protein) was frozen and thawed up to three
times at -20 °C (15 min) and 37 °C (5 min) before being
applied to gel retardation assays and Western hybridisa-
tion analysis.
For S. coelicolor CE, cells from 25 ml samples of indi-
vidual 60 ml SMM liquid cultures were collected at dif-
ferent phases of growth (Table 2, GC 1). Fresh CE was
prepared with all cells obtained as described for E. coli
using 100, 150 or 200 μl disruption buffer with glycerol.
500 μg total CE protein was used for Western analysis
and gel retardation assays shown in Figure 8.
Gel retardation analysis
Gel retardation experiments were carried out as
described previously [9] using the Roche DIG Gel Shift
Kit (Roche cat No. 1635352). From a genomic DNA iso-
late of S. coelicolor M145, a 177 bp PCR fragment con-
taining the ScbR binding site in the promoter region of
scbR [9] was amplified using primers ETS6 and ETS10
and then was DIG-labelled according to the manufac-
turer’s manual. For each sample approximately 0.23 ng
(Figure 11A) and 1.8 ng (Figure 10) were used. For the
results shown in Figure 8A, primer ETS10 was replaced
by ETS10_DIG(5’) with digoxygenin linked to the 5’-end
of the primer to obtain a labelled probe directly from
PCR of which 5 ng was used in each sample (all primers
are listed in Additional file 2). In some cases, 8 or 63 ng
of chemically synthesised S. coelicolor γ-butyrolactoneSCB1 was added to the mixture prior to incubation (Fig-
ure 10). For Figure 10, a Super RX Medical X-ray Film
(NIF100) (Fujifilm) and a Konica QX-150U Medical Film
Processor were used for detection. Pictures for
Figure 8A and Figure 11A were obtained with the Lumi-
Imager F1 (Roche) and the Luminescent Image analyzer
LAS-4000 (Fujifilm), respectively.
Complementation of a S. coelicolor M145ΔscbR mutant
(M752) with ScbRM145 and ScbRM600 by chromosomal
replacement
scbRM145 and scbRM600 complementation vectors were
constructed as described in detail in Additional file 7A,
B, C, D, E. Resulting plasmids pTE212 and pTE214 con-
tain a 2.4 kb fragment of scbRM600 and scbRM145 and its
flanking regions, respectively, in the conjugative, non-
integrative vector pKC1132 [32] which is non-replicating
in S. coelicolor. The 2.4 kb inserts were sequenced and
differ only by the natural point mutation in scbRM600
(this study) and an additional silent point mutation,
c636t, in scbRM145 of pTE214 with no effect on the
amino acid sequence of ScbRM145. pTE212 and pTE214
were transferred into S. coelicolor M752 by conjugation
via E. coli ET12567/pUZ8002. Single- and double-
crossover mutants were selected as described in [9], but
using DNAgar for non-selective growth, yielding strains
LW33 and LW34 in which the truncated scbRM145 re-
gion of the M145ΔscbRM145 mutant M752 was replaced
by scbRM600 and scbRM145, respectively, in a M145
chromosomal background. Presence of full-length scbR
genes at the right chromosomal location was confirmed
by PCR using primers ETseq3 and ETS7 and Southern
analysis [18] using a PCR-generated 484 bp probe (pri-
mers scbArt1 and scbArt2 labelled with a DIG DNA la-
belling kit (Roche) binding to a 2.37 kb DNA fragment
of NcoI digested chromosomal DNA in the presence of
full-length scbR (Figure 4A,B). With the in-frame dele-
tion in scbRM145 in M752, an NcoI restriction site disap-
pears and the probe binds to a 3.2 kb DNA fragment.
The two variants of scbR in LW33 and LW34 were con-
firmed by specific PCR using primers RCseq31 and
scbR-M145_c358 or scbR-M600_c358a (Figure 4C) and
by DNA sequence analysis of the full-length scbR PCR
product shown in Figure 4C (data not shown). All pri-
mers are listed in Additional file 2.
Reverse transcription and quantitative RT-PCR
RNA was isolated as previously described [10] from
LW33 and LW34 grown in duplicate in liquid SMM at
different times of growth. cDNA synthesis and quantita-
tive RT-PCR was conducted as reported in [12].Three
technical replicates per gene and time point were done
and hrdB was used as endogenous control. All primers
used for the qRT experiments are listed in Additional
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and the original study data are available as Additional
file 8, data for growth curve 2 are shown in Figure 7.
Detection of γ-butyrolactone production in liquid S.
coelicolor cultures
S. coelicolor LW33 and LW34 were grown in liquid
SMM at 30 °C. At four time points (Table 2, GC 2), γ-
butyrolactones were extracted from the culture super-
natant as described in [9] and detected by the kanamycin
bioassay [21].109 spores per plate of the indicator strain
were plated out for confluent lawns on DNAgar plates
containing 5 μg kanamycin ml-1. Each 5 μl of the γ-
butyrolactones extracts, as well as 125 ng of the γ-
butyrolactone SCB1 as positive control and the solvent
methanol as negative control were spotted in the middle
of the plates. After incubation for 3 days at 30 °C growth
of the indictor strain was determined; pictures were
taken from the bottom (Figure 6).
Determination of secondary metabolite production
4 x 107 spores per plate of S. coelicolor were streaked
out for a 2.5 x 2.5 cm square on Glu-DNAgar, and pic-
tures were taken from the bottom at different phases of
growth to determine production of pigmented secondary
metabolites (Figure 5). Antibiotic production in liquid
cultures was determined as described previously [33].
Additional files
Additional file 1: Data from the chymotryptic digests.
Additional file 2: Primers used for (qRT-)PCR experiments.
Additional file 3: Partial multi-sequence alignment of
sequencedscbR homologues in Streptomyces. The scbR homologous
coding region in various S. coelicolor strains (indicated on the left) and in
S. lividans 1326 was (partially) amplified by PCR and the sequences were
determined (see Methods). Point mutations compared to scbRM145 are
indicated in bold.
Additional file 4: Transcriptional analysis of redD, actII-orf4, cpkO,
scbA and scbRM145/M600 using qRT-PCR in GC 1. A. qRT-PCR analysis of
the transcription of redD, actII-orf4, cpkO, scbA and scbRM145/M600 using
cDNA synthesized from RNA isolated from liquid SMM cultures of S.
coelicolor LW34 (scbRM145) and LW33 (scbRM600). Samples were taken at
four time points (tp 1–4) during different phases of growth indicated
with eT, mT, lT and S (early, mid, late transition, and stationary phase).
Gene expression is shown as fold-change relative to the LW34 time point
1 early transition phase sample. Error bars indicate the standard deviation
(see data in Additional file 3, GC 1). B. Numerical data from of the original
qRT-PCR results.
Additional file 5: Plasmids and cosmids used in this study.
Additional file 6: Construction of the ScbRM600 expression vector
pTE58. From a genomic DNA isolate of S. coelicolor strain M600, a
931 bp PCR fragment containing the scbRM600 coding sequence and
the scbR promoter region was amplified using primers ETS3 and
ScbR2 (Additional file 2). The PCR product was gel-purified and ligated
to pDRIVE (Qiagen), yielding pTE51 of which the insert contains not only
the natural mutation c358a in scbRM600, but also additional mutations:
a30g in scbA is located in the promoter region of scbR, and nucleotide
change t587a in the coding sequence of scbRM600, respectively. The pointmutation t587a leads to an amino acid change, D196V, in ScbRM600 (data
not shown). A 948 bp pTE51/EcoRI scbRM600 fragment was cloned into
the pUC18 derivate pIJ2925 to gain pTE53 containing all three described
mutations (A). A 844 bp pTE53/PstI fragment containing the scbR
promoter region and nucleotides 1-535 of the scbRM600 coding region
was ligated into a 3103 bp pIJ6120/PstI vector fragment [9] containing
nucleotides 536–648 of the scbRM145 coding region, yielding pTE56.
Partial sequence analysis of pTE56 revealed only the scbR promoter
mutation a30g in scbA and the expected coding sequence mutation
c358a of scbRM600. A 851 bp pTE56/SacII fragment containing nucleotides
54–304 of scbRM600 was cloned into a 3047 bp pIJ6120/SacII vector
fragment containing the scbR promoter region and nucleotides 1–53 and
305–648 of the scbRM145 coding sequence, yielding pTE58 with scbR M600
and the scbR promoter region without additional undesired mutations in
the same orientation as the IPTG-inducible E. coli lacZ promoter (B). The
scbRM145 expression construct pIJ6120 [9] and pTE58 differ only by the
natural mutation, c358a, in scbRM600 and were used for the heterologous
expression of ScbRM145 and ScbRM600 in E. coli. Linear DNA fragments are
named and a scale is given with indicated base pair (bp) units. Plasmids
are named and represented by black circles. Genes are indicated by dark
arrows and labelled with gene names. For incomplete genes, the missing
part is indicated by an apostrophe at the beginning or the end of the
gene name. Antibiotic resistance genes are abbreviated with “amp” for
ampicillin and “apra” for apramycin. “lacZ’” denotes for the LacZ α-
peptide coding sequence. The position of the described mutations is
indicated by labelled grey boxes on the scales and in the plasmid maps;
relevant restriction sites are shown with enzyme names. Thick black lines
with arrows indicate ligation events; big black arrows with enzyme
names indicate corresponding restriction steps.
Additional file 7: Construction of the complementation vectors
pTE212 and pTE214. From genomic DNA isolates of S. coelicolor strains
M145 and M600, a 2406 bp PCR fragment containing the scbRM145/M600
coding sequence and flanking regions was amplified using primers
BamRCseq31enh and BamETseq1 (Additional file 2). PCR products were
gel-purified and ligated to pGEM-T EASY (Promega), yielding pTE63
harbouring scbRM145 (A), and pTE64 (B) and pTE203 (C) harbouring
scbRM600. The inserts of the plasmids were sequenced and pTE63 was
found to contain mutations in scbRM145 (silent mutation c636t) and scbA
(c308t leading to A103V). pTE64 contains a mutation in scbA (t77c
leading to M26T), and pTE203 in scbB (c644t leading to A215V). Two 1405
bp pTE203/PstI fragments were introduced by tandem integration into a
4016 bp pTE64/PstI vector fragment to give pTE211, which is pGEM-T
EASY with a 2394 bp BamHI scbRM600 fragment without any additional
mutations and an additional 1.4 kb BamHI fragment. The 2394 bp
pTE211/BamHI fragment was cloned into pKC1132 to give pTE212 (D). A
1269 bp pTE63/NcoI fragment containing the silent mutation c636t in
scbRM145 was cloned into a 4152 bp pTE211/NcoI vector fragment to give
pTE213, which is pGEM-T EASY with a 2394 bp BamHI scbRM145 fragment
with only the silent mutation. The 2394 bp pTE213/BamHI fragment was
cloned into pKC1132 to give pTE214 (E). Linear DNA fragments are
named and a scale is given with indicated base pair (bp) units. Plasmids
are named and represented by black circles. Genes are indicated by dark
arrows and labelled with gene names. For incomplete genes, the missing
part is indicated by an apostrophe at the beginning or the end of the
gene name. The ampicillin antibiotic resistance gene is abbreviated with
“amp”. The position of the described mutations is indicated by labelled
grey boxes on the scales and in the plasmid maps; relevant restriction
sites are shown with enzyme names. Thick black lines with arrows
indicate ligation events; big black arrows with enzyme names indicate
corresponding restriction steps.
Additional file 8: Excel file containing original qRT-PCR results.
Competing interests
None of the authors have a competing interest.
Authors’ contributions
MG, AH, RB, and PP conducted the experiments. AH and ET designed the
experiments. MG, AH and ET analysed the results and wrote the manuscript.
All authors read and approved the final manuscript.
Gottelt et al. BMC Research Notes 2012, 5:379 Page 16 of 17
http://www.biomedcentral.com/1756-0500/5/379Acknowledgements
We thank D. Weaver and C. M. Kao for the provision of numerous S.
coelicolor strains. We thank Atze van der Pol for technical assistance. MG was
funded by the EU FP6 programme ActinoGEN (Project No. FP6 – 5224), RB
was funded by Deutsche Forschungsgemeinschaft (TA428/2-1)
DFG-Forschergruppe 449 ‘Bacterial cell envelope’. ET was supported by a
Rosalind Franklin Fellowship from the University of Groningen.
Author details
1Department of Microbial Physiology, Groningen Biomolecular Sciences and
Biotechnology Institute, University of Groningen, Nijenborgh 7, 9747 AG
Groningen, The Netherlands. 2Present address: Life Technologies, Frankfurter
Str. 129b, 64293 Darmstadt, Germany. 3Department of Molecular
Microbiology, John Innes Centre, Norwich Research Park, Colney, Norwich
NR4 7UH, UK. 4Present address: Department of Biochemistry, New Building
(Sanger), 80 Tennis Court Road, Old Addenbrooke's Site, Cambridge CB2
1GA, UK. 5Present address: Équipe de Biologie Moléculaire Marine - PROTEE,
Université du Sud Toulon-Var, BP 20132, Avenue de l'Université, 83957 La
Garde Cedex, France. 6Present address: Department of Enzymology,
Groningen Biomolecular Sciences and Biotechnology Institute, University of
Groningen, Nijenborgh 4, 9747 AG Groningen, The Netherlands.
Received: 24 February 2012 Accepted: 27 July 2012
Published: 27 July 2012References
1. Champness W: Actinomycete development, antibiotic production and
phylogeny: questions and challanges. In Prokaryotic Development.
Edited by Brun YV, Skimkets LJ. Washington, DC, USA: ASM Press;
2000:11–31.
2. Miyadoh S: Research on antibiotic screening in Japan over the
ILastdecade: A producing microorganism approach. Actinomycetologica
1993, 7:100–106.
3. Bentley SD, Chater KF, Cerdeno-Tarraga AM, Challis GL, Thomson NR, James
KD, Harris DE, Quail MA, Kieser H, Harper D, Bateman A, Brown S, Chandra
G, Chen CW, Collins M, Cronin A, Fraser A, Goble A, Hidalgo J, Hornsby T,
Howarth S, Huang CH, Kieser T, Larke L, Murphy L, Oliver K, O'Neil S,
Rabbinowitsch E, Rajandream MA, Rutherford K, Rutter S, Seeger K, Saunders
D, Sharp S, Squares R, Squares S, Taylor K, Warren T, Wietzorrek A,
Woodward J, Barrell BG, Parkhill J, Hopwood DA: Complete genome
sequence of the model actinomycete Streptomyces coelicolor A3(2).
Nature 2002, 417:141–147.
4. Weaver D, Karoonuthaisiri N, Tsai HH, Huang CH, Ho ML, Gai S, Patel KG,
Huang J, Cohen SN, Hopwood DA, Chen CW, Kao CM: Genome plasticity
in Streptomyces: identification of 1 Mb TIRs in the S. coelicolor A3(2)
chromosome. Mol Microbiol 2004, 51:1535–1550.
5. Takano E: Gamma-butyrolactones: Streptomyces signalling molecules
regulating antibiotic production and differentiation. CurrOpin Microbiol
2006, 9:287–294.
6. Horinouchi S, Beppu T: Regulation of secondary metabolism and cell
differentiation in Streptomyces: A-factor as a microbial hormone and the
AfsR protein as a component of a two-component regulatory system.
Gene 1992, 115:167–172.
7. Horinouchi S: A microbial hormone, A-factor, as a master switch for
morphological differentiation and secondary metabolism inStreptomyces
griseus. Front Biosci 2002, 7:d2045–d2057.
8. Takano E, Nihira T, Hara Y, Jones JJ, Gershater CJ, Yamada Y, Bibb M:
Purification and structural determination of SCB1, a gamma-
butyrolactone that elicits antibiotic production in Streptomyces
coelicolorA3(2). J BiolChem 2000, 275:11010–11016.
9. Takano E, Chakraburtty R, Nihira T, Yamada Y, Bibb MJ: A complex
role for the gamma-butyrolactone SCB1 in regulating antibiotic
production in Streptomyces coelicolorA3(2). MolMicrobiol 2001,
41:1015–1028.
10. Takano E, Kinoshita H, Mersinias V, Bucca G, Hotchkiss G, Nihira T, Smith CP,
Bibb M, Wohlleben W, Chater K: A bacterial hormone (the SCB1) directly
controls the expression of a pathway-specific regulatory gene in the
cryptic Type I polyketide biosynthetic gene cluster ofStreptomyces
coelicolor. MolMicrobiol 2005, 56:465–479.11. Pawlik K, Kotowska M, Chater KF, Kuczek K, Takano E: A cryptic Type I
polyketide synthase (cpk) gene cluster inStreptomyces coelicolorA3(2).
Arch Microbiol 2007, 187:87–99.
12. Gottelt M, Kol S, Gomez-Escribano JP, Bibb M, Takano E: Deletion of a
regulatory gene within the cpk gene cluster reveals novel antibacterial
activity inStreptomyces coelicolor A3(2). Microbiology 2010,
156:2343–2353.
13. Ramos JL, Martinez-Bueno M, Molina-Henares AJ, Teran W, Watanabe K,
Zhang X, Gallegos MT, Brennan R, Tobes R: The TetR family of
transcriptional repressors. Microbiol Mol Biol Rev 2005,
69:326–356.
14. Natsume R, Ohnishi Y, Senda T, Horinouchi S: Crystal structure of a
gamma-butyrolactoneautoregulator receptor protein inStreptomyces
coelicolorA3(2). J MolBiol 2004, 336:409–419.
15. Finley EL, Dillon J, Crouch RK, Schey KL: Identification of tryptophan
oxidation products in bovine alpha-crystallin. Protein Sci 1998,
7:2391–2397.
16. Sambrook J, Russell DW: Molecular cloning: a laboratory manual. New York:
Cold Spring Harbor Laboratory Press; 2001.
17. MacNeil DJ, Occi JL, Gewain KM, MacNeil T, Gibbons PH, Ruby CL, Danis SJ:
Complex organization of the Streptomyces avermitilis genes encoding
the avermectin polyketide synthase. Gene 1992, 115:119–125.
18. Kieser T, Bibb MJ, Buttner MJ, Chater KF, Hopwood DA: Practical
Streptomyces Genetics. Norwich, United Kingdom: John Innes Foundation;
2000.
19. Yang YH, Song E, Kim JN, Lee BR, Kim EJ, Park SH, Kim WS, Park HY, Jeon
JM, Rajesh T, Kim YG, Kim BG: Characterization of a new ScbR-like γ-
butyrolactone binding regulator (SlbR) in Streptomyces coelicolor.
ApplMicrobiol Biotechnol 2012, doi:10.1007/s00253-011-3803-4.
20. Chakraburtty R, Bibb M: The ppGppsynthetase gene (relA) of
Streptomyces coelicolor A3(2) plays a conditional role in antibiotic
production and morphological differentiation. J Bacteriol 1997,
179:5854–5861.
21. Hsiao NH, Nakayama S, Merlo ME, de Vries M, Bunet R, Kitani S, Nihira T,
Takano E: Analysis of two additional signaling molecules inStreptomyces
coelicolorand the development of a butyrolactone-specific reporter
system. ChemBiol 2009, 16:951–960.
22. Sugiyama M, Onaka H, Nakagawa T, Horinouchi S: Site-directed
mutagenesis of the A-factor receptor protein: Val-41 important for
DNA-binding and Trp-119 important for ligand-binding. Gene 1998,
222:133–144.
23. Bibb MJ: Regulation of secondary metabolism in streptomycetes.
CurrOpin Microbiol 2005, 8:208–215.
24. Lu Y, Wang W, Shu D, Zhang W, Chen L, Qin Z, Yang S, Jiang W:
Characterization of a novel two-component regulatory system involved
in the regulation of both actinorhodin and a type I polyketide in
Streptomyces coelicolor. ApplMicrobiol Biotechnol 2007,
77:625–635.
25. Rigali S, Titgemeyer F, Barends S, Mulder S, Thomae AW, Hopwood DA,
van Wezel GP: Feast or famine: the global regulator DasR links nutrient
stress to antibiotic production byStreptomyces. EMBO Rep 2008,
9:670–675.
26. Mullis K, Faloona F, Scharf S, Saiki R, Horn G, Erlich H: Specific enzymatic
amplification of DNA in vitro: the polymerase chain reaction. Cold Spring
HarbSymp Quant Biol 1986, 51(Pt 1):263–273.
27. Leblond P, Fischer G, Francou FX, Berger F, Guerineau M, Decaris B: The
unstable region of Streptomyces ambofaciens includes 210 kb terminal
inverted repeats flanking the extremities of the linear chromosomal
DNA. MolMicrobiol 1996, 19:261–271.
28. Hesketh AR, Chandra G, Shaw AD, Rowland JJ, Kell DB, Bibb MJ, Chater KF:
Primary and secondary metabolism, and post-translational protein
modifications, as portrayed by proteomic analysis ofStreptomyces
coelicolor. MolMicrobiol 2002, 46:917–932.
29. Redenbach M, Kieser HM, Denapaite D, Eichner A, Cullum J, Kinashi H,
Hopwood DA: A set of ordered cosmids and a detailed genetic and
physical map for the 8 MbStreptomyces coelicolorA3(2) chromosome.
MolMicrobiol 1996, 21:77–96.
30. Motejadded H, Altenbuchner J: Construction of a dual-tag system for
gene expression, protein affinity purification and fusion protein
processing. BiotechnolLett 2009, 31:543–549.
Gottelt et al. BMC Research Notes 2012, 5:379 Page 17 of 17
http://www.biomedcentral.com/1756-0500/5/37931. Laemmli UK: Cleavage of structural proteins during the assembly of the
head of bacteriophage T4. Nature 1970, 227:680–685.
32. Bierman M, Logan R, O'Brien K, Seno ET, Rao RN, Schoner BE: Plasmid
cloning vectors for the conjugal transfer of DNA fromEscherichia
colitoStreptomyces spp. Gene 1992, 116:43–49.
33. Strauch E, Takano E, Baylis HA, Bibb MJ: The stringent response
inStreptomyces coelicolorA3(2). MolMicrobiol 1991, 5:289–298.
doi:10.1186/1756-0500-5-379
Cite this article as: Gottelt et al.: Characterisation of a natural variant of
the γ-butyrolactone signalling receptor. BMC Research Notes 2012 5:379.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
